Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is six-membered and includes at least nitrogen and sulfur as ring members > Polycyclo ring system having the six-membered hetero ring as one of the cyclos (e.g., 1,3- and 1,4- benzothiazines, etc.) > Patents

Resources

Home

Browse by:

Browse by Category: Main > Health & Medicine

Class Information
Number: 514/224.2
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is six-membered and includes at least nitrogen and sulfur as ring members > Polycyclo ring system having the six-membered hetero ring as one of the cyclos (e.g., 1,3- and 1,4- benzothiazines, etc.)
Description: Subject matter in which the six-membered hetero ring is one of the cyclos of a polycyclo ring system.

Sub-classes under this class:

Class Number	Class Name	Patents
514/224.5	At least three cyclos in the polycyclo ring system	181
514/226.5	One of the cyclos is a 1,2-thiazine (e.g.,1,2-benzothiazines, etc.)	172

Patents under this class:

1 2 3 4 5 6

Patent Number	Title Of Patent	Date Issued
6727243	Compositions comprising cefuroxime axetil	Apr. 27, 2004
6727258	Allosteric adenosine receptor modulators	Apr. 27, 2004
6713477	Hydroxamic acid derivatives	Mar. 30, 2004
6706713	Conjugate for treating inflammatory infectious and/or skin diseases	Mar. 16, 2004
6696435	Substituted N,N-disubstituted fused-heterocyclo amino compounds useful for inhibiting cholesteryl ester transfer protein activity	Feb. 24, 2004
6602868	Treatments for restless legs syndrome	Aug. 5, 2003
6531484	Pyrrolidine modulators of CCR5 chemokine receptor activity	Mar. 11, 2003
6531469	Substituted 1-(4-piperidyl)-3-(aryl) isothioureas their preparation and their therapeutic application	Mar. 11, 2003
6509335	Benzoxazinoes/benzothiazinones as serine protease inhibitors	Jan. 21, 2003
6468996	Substituted hetero-polycyclic compounds as PPAR.alpha. and PPAR.gamma. activators	Oct. 22, 2002
6455519	Use of substituted N, N-disubstituted fused-heterocyclo amino compounds for inhibiting cholesteryl ester transfer protein activity	Sep. 24, 2002
6448008	Fluorescent cyanine labels containing a sulfamido linker arm	Sep. 10, 2002
6448246	Substituted 4H-1,4-benzothiazine-2-carboxamide: GABA brain receptor ligands	Sep. 10, 2002
6432964	Fungicides	Aug. 13, 2002
6432946	3-aminoalkylamino-2H-1,4-benzoxazines and 3-aminoalkylamino-2H-1,4-benzothiazines: dopamine receptor subtype specific ligands	Aug. 13, 2002
6423699	Combination therapies using benzimidazolones	Jul. 23, 2002
6387896	Bicyclic oxazolidinones as antibacterial agents	May. 14, 2002
6380235	Benzimidazolones and analogues	Apr. 30, 2002
6348457	4-[3-benzofuranyl]piperidinyl and 4-[3-benzothienyl]piperidinyl derivatives	Feb. 19, 2002
6348460	1,2,3-thiadiazole derivatives, plant disease controller and method for using the same	Feb. 19, 2002
6346529	Antiviral therapy using thiazine dyes	Feb. 12, 2002
6339084	Process for the production of thiazine-indigo pigments	Jan. 15, 2002
6313113	Heterocyclic compounds having antidiabetic, hypolipidemic and antihypertensive properties, process for their preparation and pharmaceutical compositions containing them	Nov. 6, 2001
6306437	Apomorphine-containing dosage forms for ameliorating male erectile dysfunction	Oct. 23, 2001
6300342	Antithrombotic phenylalkyl derivatives	Oct. 9, 2001
6281208	Therapeutic agent for glaucoma	Aug. 28, 2001
6274619	Amidino substituted tetrahydrobenzo thiophene or furan derivatives and their use as urokinase inhibitors	Aug. 14, 2001
6271223	Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha-1-blocking action	Aug. 7, 2001
6232310	Fused 1,4-thiazine-2-carbonitrile derivatives, their preparation and use	May. 15, 2001
6228855	Aromatic esters of camptothecins and methods to treat cancers	May. 8, 2001
6225050	Cyanine dyes as labeling reagents for detection of biological and other materials by luminescence methods	May. 1, 2001
6214824	Use of amiloride for treating cancer	Apr. 10, 2001
6200971	Bicyclic heterocyclic compounds	Mar. 13, 2001
6194402	Enhancement of return to independent living status with a growth hormone secretagogue	Feb. 27, 2001
6191127	Substituted heterocycles and their use in medicaments	Feb. 20, 2001
6169105	Potentiation of drug response	Jan. 2, 2001
6133258	Inhibitor of kainic acid neurotoxicity and pyridothiazine derivative	Oct. 17, 2000
6130214	Benzothiazin and benzoxazin derivatives; their preparation and uses	Oct. 10, 2000
6127357	N-((phenyl, benzodioxinyl or N-heteroarylpiperazinyl)alkyl)-N-(N-heteroaryl)substituted carboxamides	Oct. 3, 2000
6114350	Cyanine dyes and synthesis methods thereof	Sep. 5, 2000
6110910	Carbocyclic heterocyclic fused-ring quinolinecarboxylic acids useful as immunosuppressive agents	Aug. 29, 2000
6107308	Piperidine derivatives	Aug. 22, 2000
6100255	3-aminoalkylamino-2H-1,4-benzoxazines and 3-aminoalkylamino-2H-1,4-benzothiazines: dopamine receptor subtype specific ligands	Aug. 8, 2000
6096771	Isoxazole derivatives	Aug. 1, 2000
6093710	Benzothiophene derivatives, their preparation and use as urokinase inhibitors	Jul. 25, 2000
6087360	Method of treating heart failure with endothelin antagonists	Jul. 11, 2000
6080737	Uveitis remedy	Jun. 27, 2000
6057314	Low molecular weight bicyclic thrombin inhibitors	May. 2, 2000
6057317	Heterocyclic compounds	May. 2, 2000
6046211	Amidino derivatives useful as nitric oxide synthase inhibitors	Apr. 4, 2000